Mark R. Kelley - Chief Scientific Officer & Founder @ Apexian Pharmaceuticals

Indiana University School of Medicine Member, Eugene & Marilyn Glick Eye InstituteFeb 2020
Indiana University School of Medicine Professor, Department of OphthalmologyFeb 2020
Indiana University School of Medicine Glenn W. Irwin, Jr., M.D. Research ScholarJul 2018
Indiana University School of Medicine Bantz-Petronio Translating Research Into Practice AwardMay 2017
Indiana University School of Medicine Betty and Earl Herr Chair and Professor of Pediatric Oncology ResearchJul 2008
Apexian Pharmaceuticals Chief Scientific Officer & Founder2008
Indiana University School of Medicine Translating Research into Practice (TRIP) Scholar2008
Indiana University School of Medicine Associate Director, Indiana University Simon Cancer CenterOct 2006
Indiana University School of Medicine Associate Director, IU Pancreatic Cancer Signature Center2001
Indiana University School of Medicine Professor, Departments of Pediatrics, Biochemistry & Molecular Biology and Pharmacology & Toxicology1999

Organization Name	Title At Company	Start Date	End Date
Indiana University School of Medicine	Associate Director, Wells Center for Pediatric Research	Jul 1995	Jul 2017
Indiana University School of Medicine	Co-Director, Chemical Biology and Drug Discovery Initiative	2012	2015

Related Hubs

Hub Name	CB Rank (Hub)
Indianapolis Companies With Fewer Than 1000 Employees	20,032
Elevate Ventures Portfolio Companies	78,188
Indiana Companies With Less Than $50M in Revenue (Top 10K)	8,217
Indiana Companies With Fewer Than 1000 Employees (Top 10K)	6,328
Indiana Health Care Companies	20,381
Private Indiana Companies (Top 10K)	4,736
Indiana Companies With Less Than $1B in Revenue (Top 10K)	7,514
Midwestern US Health Care Companies (Top 10K)	2,272
Indiana Companies With Fewer Than 50 Employees (Top 10K)	8,781
Indianapolis Companies With Less Than $50M in Revenue	23,332

studied at

There is no recent news or activity for this profile.